Welcome to our dedicated page for Cross Ctry Healthcare SEC filings (Ticker: CCRN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Cross Country Healthcare, Inc. (CCRN) SEC filings page on Stock Titan provides centralized access to the company’s public filings with the U.S. Securities and Exchange Commission. As a Nasdaq-listed issuer, Cross Country Healthcare submits a range of documents that detail its financial condition, governance, and material corporate events.
Investors can use this page to locate current and historical reports such as annual reports on Form 10‑K and quarterly updates on Form 10‑Q, which the company references in its proxy materials and earnings communications. These reports typically include audited or reviewed financial statements, segment information for Nurse and Allied Staffing and Physician Staffing, discussions of Homecare and Education staffing activities, and management’s analysis of operational efficiency, technology investments, and market conditions.
The filings page also surfaces current reports on Form 8‑K, which Cross Country Healthcare uses to disclose significant events. Recent examples include 8‑Ks reporting quarterly financial results furnished under Item 2.02, updates on the Agreement and Plan of Merger with Aya Healthcare and its termination, the automatic extension of the merger agreement end date, the scheduling of the 2025 Annual Meeting of Stockholders, and the CEO transition in which co‑founder and Chairman Kevin C. Clark was appointed President and Chief Executive Officer.
In addition, users can review the company’s definitive proxy statements on Schedule 14A, which describe board composition, director qualifications, executive compensation, and key proposals submitted to stockholders. These documents also summarize strategic priorities such as strengthening the operational foundation, advancing technology capabilities, and addressing workforce needs across healthcare, homecare, and education markets.
Stock Titan enhances these filings with AI-powered summaries that explain the key points of lengthy documents, helping readers quickly understand the implications of new 10‑K, 10‑Q, 8‑K, and proxy filings. Real-time updates from EDGAR, combined with simplified explanations of complex disclosures, make it easier to track Cross Country Healthcare’s regulatory reporting and governance developments, including items related to potential transactions, capital allocation, and leadership changes.
Cross Country Healthcare, Inc. detailed the exit arrangements for former Chief Information Officer Phil Noe. As previously disclosed, he ceased serving as CIO effective March 10, 2026. On March 16, 2026, the company and Mr. Noe entered into a Separation Agreement and an Independent Contractor Agreement.
Under the Separation Agreement, Mr. Noe will receive $205,975 in severance, equal to six months of his current base salary, paid in bi-weekly installments over six months, provided he does not revoke his waiver and release within seven days of signing. Separately, the Consulting Agreement engages him from March 11, 2026 through May 31, 2026 to provide technology and infrastructure consulting services at a rate of $198.04 per hour, with early termination permitted by mutual written agreement.
CROSS COUNTRY HEALTHCARE INC Chief Human Resources Officer Colin Patrick McDonald sold 6,200 shares of common stock in an open-market transaction on March 11, 2026 at a weighted average price of about $9.70 per share. After this sale, he directly holds 28,060 shares of the company’s common stock.
Morgan Stanley Smith Barney LLC submitted a Form 144 notice proposing the sale of 6,200 shares of Common Stock (listed on NASDAQ), dated 03/11/2026. The notice breaks the position into three grant types: 3,046 performance shares (03/31/2023), 1,117 restricted stock (03/31/2023), and 2,037 performance shares (03/31/2024).
Cross Country Healthcare, Inc. announced leadership changes in its finance and technology functions. Effective March 10, 2026, James V. Redd III will step down as Senior Vice President and Chief Accounting Officer, and Phil Noe will step down as Chief Information Officer. The company states that neither departure results from any dispute or disagreement, including on accounting practices or financial reporting.
The Board appointed longtime employee Marvin Veizaga as Senior Vice President and Chief Accounting Officer, effective the same date. Veizaga has been with the company since 2015 in increasingly senior controller roles and previously worked as a Senior Auditor at Deloitte & Touche LLP. Under a new Letter Agreement, his base salary will be $340,000, with an annual short-term incentive bonus target of 50% of base salary and an annual long-term equity incentive target of 50% of base salary. The company notes there are no related-party arrangements or family relationships tied to his appointment.
Cross Country Healthcare, Inc. filed its annual report describing its AI‑driven healthcare staffing and workforce solutions business across nursing, allied, physician, education, and PACE programs in all 50 U.S. states. The company notes that Aya Holdings terminated a planned merger and paid a $20.0 million cash termination fee.
Following the deal’s end, co‑founder and Chairman Kevin C. Clark was appointed President and CEO, succeeding John A. Martins. The filing highlights ongoing investments in the Intellify® SaaS platform, AI and automation, and a largely remote, U.S.–India operating model, while detailing extensive risk factors including technology, cybersecurity, regulatory, litigation, and labor market pressures.
Cross Country Healthcare reported sharply weaker results for Q4 and full year 2025 as demand for healthcare staffing continued to soften and merger-related impacts weighed on earnings. Fourth quarter revenue was $236.8 million, down 24% from a year ago and 5% from the prior quarter, while full-year revenue fell 22% to $1.05 billion.
Profitability deteriorated significantly. Q4 net loss attributable to common stockholders widened to $82.9 million, and the full-year net loss reached $94.9 million, or $2.93 per diluted share. Results were heavily affected by a $77.9 million non-cash impairment of goodwill and trade names and a $29.6 million valuation allowance against deferred tax assets, both tied to a decline in the company’s market value after the Aya merger agreement was terminated.
On an adjusted basis, Q4 EBITDA was $4.1 million, or 1.7% of revenue, down from $9.3 million and a 3.0% margin a year earlier. Full-year adjusted EBITDA dropped to $26.8 million, or a 2.5% margin, from $49.1 million and 3.7%. Management’s outlook for Q1 2026 calls for revenue of $235 million to $240 million and adjusted EBITDA of $4.0 million to $5.0 million, implying revenue declines of roughly 18% to 20% year-over-year and substantially lower adjusted earnings.
Cross Country Healthcare, Inc. is providing an update on investor outreach activities. The company announced it is scheduled to participate in the Truist Securities Virtual Human Capital Conference on March 12–13, 2026 and the Oppenheimer 36th Annual Healthcare MedTech & Services Conference on March 16–19, 2026.
At both events, executives including Executive Vice President & Chief Financial Officer William J. Burns and Vice President of Investor Relations Josh Vogel will hold one-on-one meetings with investors, with no formal presentations planned.
CROSS COUNTRY HEALTHCARE INC executive Amiee Lin Hawkins filed an initial ownership report on Form 3. She reported direct ownership of 29,273 shares of the company’s common stock, reflecting her existing stake as Chief Solutions & Operations Officer, with no specific buy or sell transactions disclosed.
AllianceBernstein L.P. filed Amendment No. 2 to a Schedule 13G/A reporting its beneficial ownership of Cross Country Healthcare Inc. common stock. As of 12/31/2025, AllianceBernstein reported beneficial ownership of 31,215 shares, representing 0.1% of the outstanding common stock.
The shares are held solely for investment purposes in client discretionary investment advisory accounts, with AllianceBernstein having sole voting and dispositive power over these shares and no shared power. The filing states the holdings are in the ordinary course of business and not for changing or influencing control of Cross Country Healthcare.
Cross Country Healthcare, Inc. is informing investors about its upcoming fourth quarter and full year 2025 earnings conference call. The call will take place on Wednesday, March 4, 2026 at 5:00 p.m. Eastern Time, with an earnings press release expected after market close that day.
The call will be accessible via live webcast on the company’s investor relations website at ir.crosscountry.com and by phone using listed U.S. and international dial-in numbers with the passcode “Cross Country.” A replay will be available online and by telephone from March 4 through March 18.
The filing presents this information under a Regulation FD disclosure item and includes a furnished press release as an exhibit, outlining the call logistics and offering a brief description of Cross Country Healthcare’s technology-driven healthcare workforce solutions business.